Stamford, CT -- (SBWIRE) -- 12/12/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Gazprom OAO (ADR) (OTCMKTS:OGZPY), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Emo Capital Corp. (OTCBB:NUVI), GeoVax Labs, Inc. (OTCMKTS:GOVX)
Gazprom OAO (ADR) (OTCMKTS:OGZPY) opened the session at $8.37, trading in a range of $8.19- $8.37,. The stock showed a negative performance of -2.15% in the last trading session from its previous close of $8.38 and closed at $8.20. The stock traded on a volume of 459,125 shares and the average volume of the stock remained 768,952 shares. OAO Gazprom, together with its subsidiaries, engages in the exploration and production of oil and gas. It produces crude oil and gas condensate. The company also engages in the storage, transportation, and sale of gas; and processing of oil, gas condensate, and other hydrocarbons, as well as sale of refined products. In addition, it is involved in the generation and sale of electric and heat energy.
Has OGZPY Found The Bottom and Ready To Move Up? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) traded 1.32 million shares in the last business day while the average volume of the stock remained 540,676 shares. The stock showed a positive movement of +7.77% to end at $1.11. The 52 week range of the stock remained $0.50 - $1.15. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company?s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer, and a Phase I protocol expansion candidate for liver metastasis; and PH-10, a Phase IIc randomized study initiated drug candidate for the treatment of psoriasis, and Phase II study completed candidate for atopic dermatitis.
For How Long PVCT’s Gloss will Attract Investors? Find out via this report
Emo Capital Corp. (OTCBB:NUVI) reported 12.85 million shares were exchanged during the last trade, while the average volume is about 82,603 shares. The stock escalated +34.62% and finished the day at $0.0.210. The beta of the stock is recorded at 1.98. Emo Capital Corp., through its subsidiary, Nu Vitality Labs Inc., operates as a health and beauty company. It focuses on providing Web portal for its clients, where customers can receive diet/health and fitness coaching; communicate and interact with other individuals through the Nu Vitality Labs Health & Fitness social network; and purchase health and beauty supplements through the Nu Vitality Labs Beauty Store. The company was founded in 2006 and is headquartered in Shanghai, China.
For How Long NUVI’s Gloss will Attract Investors? Find out via this report
GeoVax Labs, Inc. (OTCMKTS:GOVX) shares rose, +43.55 percent from its previous close of $0.62 to close at $0.890. Traded with volume of 625,428 shares in the prior session and the average volume of the stock remained 69,647 shares. GeoVax Labs, Inc. operates as a biotechnology company. It focuses on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). The company?s vaccines under development address the clade B subtype of the HIV virus. Its vaccines incorporate two vaccine delivery components, including a recombinant DNA and recombinant poxvirus, known as modified vaccinia Ankara, which deliver genes that encode inactivated HIV derived proteins to the immune system.
Why Should Investors Buy GOVX After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)